Parkinson’s, How it Differs from Alzheimer’s, Biomarkers, and the Major Challenges the Community Face

Parkinson’s, How it Differs from Alzheimer’s, Biomarkers, and the Major Challenges the Community Face

Since the discovery of dopamine as a neurotransmitter in the 1950s, Parkinson’s disease (PD) research has generated a rich and complex body of knowledge, revealing PD to be an age-related multifactorial disease, influenced by both genetic and environmental factors. The tremendous complexity of the disease is increased by a nonlinear progression of the pathogenesis between molecular, cellular and organic systems.

read more
Four Types of EEGs

Four Types of EEGs

EEGs – or electroencephalograms – are used to diagnose many neurological conditions. Depending on the condition, your health care provider may order one of four different types of EEGs.

read more